Medical Research Articles Published in February 1993

With a Free Docphin Account, you create a custom list of medical research journal sources that are easy to navigate, search our extensive databse of articles, save and organize your articles into folders, set up alerts to be notificed of research articles that match your interests ... and much more.

Login or Register
02/01/1993
Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. (PubMedID: 8094583) Transplantation
02/01/1993
High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients. (PubMedID: 8381990) Transplantation
02/01/1993
The effect of cyclosporine and liver autotransplantation on bile flow and composition in dogs. (PubMedID: 8434370) Transplantation
02/01/1993
Successful intracerebroventricular allotransplantation of parathyroid tissue in rats without immunosuppression. (PubMedID: 8434371) Transplantation
02/01/1993
The effect of protease inhibitor on reperfusion injury after unilateral pulmonary ischemia. (PubMedID: 8434372) Transplantation
02/01/1993
Essential fatty acid deficiency increases interstitial IA-positive cells in rat kidney and accelerates renal allograft rejection. (PubMedID: 8434373) Transplantation
02/01/1993
Absence of tolerance to noninherited maternal transplantation antigens expressed on skin and cornea. (PubMedID: 8434374) Transplantation
02/01/1993
The effect of hepatic ischemia-reperfusion on polyamine metabolism in some organs of the rat. (PubMedID: 8434375) Transplantation
02/01/1993
A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipients. (PubMedID: 8434376) Transplantation
02/01/1993
Type III hyperlipoproteinemia acquired by liver transplantation. (PubMedID: 8434377) Transplantation
02/01/1993
Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. (PubMedID: 8434378) Transplantation
02/01/1993
Rapid detection of anti-OKT3 antibodies with the Transtat assay. (PubMedID: 8434379) Transplantation
02/01/1993
Diltiazem in renal allograft recipients receiving cyclosporine. (PubMedID: 8434380) Transplantation
02/01/1993
Treatment of growth failure in children after renal transplantation. (PubMedID: 8434381) Transplantation
02/01/1993
Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis. (PubMedID: 8434382) Transplantation
02/01/1993
Evidence that I-E-negative mice resistant to neonatal H-2 tolerance induction display ubiquitous thymic clonal deletion of donor-reactive T cells. (PubMedID: 8434383) Transplantation
02/01/1993
The morphology and function of rabbit hepatocytes isolated using ethylenediaminetetraacetate. (PubMedID: 8434384) Transplantation
02/01/1993
The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. (PubMedID: 8434385) Transplantation
02/01/1993
Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection. (PubMedID: 7679807) Transplantation proceedings
02/01/1993
Expression of allogeneic class II cDNA in swine peripheral blood mononuclear cells following retroviral-mediated gene transfer into bone marrow. (PubMedID: 7679808) Transplantation proceedings
02/01/1993
Rising interest in nitric oxide synthase. (PubMedID: 7683828) Trends in biochemical sciences
02/01/1993
An adhesive domain detected in functionally diverse receptors. (PubMedID: 8387703) Trends in biochemical sciences
02/01/1993
Inositol phosphates and cell signaling: new views of InsP5 and InsP6. (PubMedID: 8387704) Trends in biochemical sciences
02/01/1993
A putative fatty acid-binding domain of the NMDA receptor. (PubMedID: 8488555) Trends in biochemical sciences
02/01/1993
A data-based reaction mechanism for type I fructose bisphosphate aldolase. (PubMedID: 8488556) Trends in biochemical sciences
02/01/1993
The biochemical basis of the NADPH oxidase of phagocytes. (PubMedID: 8488557) Trends in biochemical sciences
02/01/1993
Nerve growth factor revisited. (PubMedID: 8488558) Trends in biochemical sciences
02/01/1993
Computers for molecular biologists. (PubMedID: 8488559) Trends in biochemical sciences
02/01/1993
Numerical integration of rate equations by computer. (PubMedID: 8488560) Trends in biochemical sciences
02/01/1993
William Arthur Johnson--a postgraduate's contribution to the Krebs cycle. (PubMedID: 8488561) Trends in biochemical sciences
02/01/1993
Evidence that cyclosporine causes both intracellular migration and inappropriate urinary excretion of magnesium in rats. (PubMedID: 8434386) Transplantation
02/01/1993
Protection of islets of Langerhans from antibodies by microencapsulation with alginate-poly-L-lysine membranes. (PubMedID: 8434387) Transplantation
02/01/1993
Characterization of maturation and function of natural killer cells in xenogeneic (rat-->mouse) bone marrow chimeras. Evidence that rat NK cells are present and functional in a xenogeneic environment. (PubMedID: 8434388) Transplantation
02/01/1993
Suppression of graft-versus-host disease by succinyl acetone in a rat allogeneic bone marrow transplantation model. (PubMedID: 8434389) Transplantation
02/01/1993
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2. (PubMedID: 8434390) Transplantation
02/01/1993
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts. (PubMedID: 8434391) Transplantation
02/01/1993
Kidney cell-restricted recognition of MHC class I alloantigens by human cytolytic T cell clones. (PubMedID: 8434392) Transplantation
02/01/1993
Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. (PubMedID: 8434393) Transplantation
02/01/1993
Successful donation and transplantation of multiple organs from a victim of cyanide poisoning. (PubMedID: 8434394) Transplantation
02/01/1993
Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys. (PubMedID: 8434395) Transplantation
02/01/1993
Rapid analysis of tumor necrosis factor-alpha mRNA expression during venoocclusive disease of the liver after allogeneic bone marrow transplantation. (PubMedID: 8434396) Transplantation
02/01/1993
Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. (PubMedID: 8434397) Transplantation
02/01/1993
Digestive tract infections in kidney and liver transplantation in a single institution. (PubMedID: 8434398) Transplantation
02/01/1993
Therapeutic in vivo use of the A1-CD3 monoclonal antibody. (PubMedID: 8434399) Transplantation
02/01/1993
Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 split. (PubMedID: 8434400) Transplantation
02/01/1993
Use of Greenfield filters in renal transplant patients--are they safe? (PubMedID: 8434401) Transplantation
02/01/1993
Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. (PubMedID: 8434402) Transplantation
02/01/1993
Absence of clinical symptoms following the first injection of anti-T cell receptor monoclonal antibody (BMA 031) despite isolated TNF release. (PubMedID: 8434403) Transplantation
02/01/1993
An alternative technique for in situ arterial flushing in elderly liver donors with atherosclerotic occlusive disease. (PubMedID: 8434404) Transplantation
02/01/1993
Use of extracorporeal membrane oxygenation for adult respiratory distress syndrome following cadaveric renal transplantation. (PubMedID: 8434405) Transplantation
02/01/1993
Osmotic pump delivery of rapamycin. (PubMedID: 8434406) Transplantation
02/01/1993
The regeneration of transplanted hepatocytes within the mesenteric fat pad of mice. (PubMedID: 8434407) Transplantation
02/01/1993
15-deoxyspergualin effects in rat heart allograft transplantation--relation to dose, timing, and cyclosporine. (PubMedID: 8434408) Transplantation
02/01/1993
Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor. (PubMedID: 8434409) Transplantation
02/01/1993
Enhanced expression of hepatocyte growth factor and c-Met mRNAs in isografts in experimental rat liver transplants. (PubMedID: 7679809) Transplantation proceedings
02/01/1993
Epitope fine specificity of human anti-HLA-A2 antibodies. (PubMedID: 7679810) Transplantation proceedings
02/01/1993
Molecular matching for clinical kidney transplantation. (PubMedID: 7679811) Transplantation proceedings
02/01/1993
HLA-DR matching effect in orthotopic liver transplantation under FK 506. (PubMedID: 7679812) Transplantation proceedings
02/01/1993
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. (PubMedID: 7679813) Transplantation proceedings
02/01/1993
The role of human CD59 antigen in discordant xenotransplantation between humans and nonprimates. (PubMedID: 7679814) Transplantation proceedings
02/01/1993
Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection. (PubMedID: 7679815) Transplantation proceedings
02/01/1993
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. (PubMedID: 7679816) Transplantation proceedings
02/01/1993
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. (PubMedID: 7679817) Transplantation proceedings
02/01/1993
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? (PubMedID: 7679818) Transplantation proceedings
02/01/1993
Cyclosporine: the base for immunosuppressive therapy--present and future. (PubMedID: 7679819) Transplantation proceedings
02/01/1993
FK 506 versus cyclosporine. (PubMedID: 7679820) Transplantation proceedings
02/01/1993
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. (PubMedID: 7679821) Transplantation proceedings
02/01/1993
Two-year experience with FK 506 in pediatric patients. (PubMedID: 7679822) Transplantation proceedings
02/01/1993
Outcome analysis of FK 506 therapy for acute and chronic rejection. (PubMedID: 7679823) Transplantation proceedings
02/01/1993
Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. (PubMedID: 7679824) Transplantation proceedings
02/01/1993
Adverse effects of FK 506 overdosage after liver transplantation. (PubMedID: 7679825) Transplantation proceedings
02/01/1993
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. (PubMedID: 7679826) Transplantation proceedings
02/01/1993
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. (PubMedID: 7679827) Transplantation proceedings
02/01/1993
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. (PubMedID: 7679828) Transplantation proceedings
02/01/1993
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. (PubMedID: 7679829) Transplantation proceedings
02/01/1993
Long-term survival of heart and liver xenografts with splenectomy and FK 506. (PubMedID: 7679830) Transplantation proceedings
02/01/1993
Japanese study of FK 506 on kidney transplantation: results of late phase II study. (PubMedID: 7679831) Transplantation proceedings
02/01/1993
Production of monoclonal antibody against recombinant human FKBP-12 and subcellular localization of FKBP-12 in human mononuclear and polymorphonuclear cells. (PubMedID: 7679832) Transplantation proceedings
02/01/1993
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. (PubMedID: 7679833) Transplantation proceedings
02/01/1993
Nucleus associated FK 506 binding proteins with potential relevance to FK 506 immunosuppression. (PubMedID: 7679834) Transplantation proceedings
02/01/1993
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. (PubMedID: 7679835) Transplantation proceedings
02/01/1993
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. (PubMedID: 7679836) Transplantation proceedings
02/01/1993
Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens. (PubMedID: 7679837) Transplantation proceedings
02/01/1993
Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. (PubMedID: 7679838) Transplantation proceedings
02/01/1993
Long-term insulin requirement after liver transplantation with FK 506 in American veterans. (PubMedID: 7679839) Transplantation proceedings
02/01/1993
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. (PubMedID: 7679840) Transplantation proceedings
02/01/1993
Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK 506, rapamycin, or RS-61443. (PubMedID: 7679841) Transplantation proceedings
02/01/1993
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. (PubMedID: 7679842) Transplantation proceedings
02/01/1993
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. (PubMedID: 7679843) Transplantation proceedings
02/01/1993
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection. (PubMedID: 7679844) Transplantation proceedings
02/01/1993
Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection. (PubMedID: 7679845) Transplantation proceedings
02/01/1993
Natural killer cell cytotoxicity and the multidrug resistance gene. (PubMedID: 7679846) Transplantation proceedings
02/01/1993
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. (PubMedID: 7680144) Transplantation proceedings
02/01/1993
Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. (PubMedID: 7680145) Transplantation proceedings
02/01/1993
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. (PubMedID: 7680146) Transplantation proceedings
02/01/1993
Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? (PubMedID: 7680147) Transplantation proceedings
02/01/1993
Intestinal transplantation in humans under FK 506. (PubMedID: 7680148) Transplantation proceedings
02/01/1993
Nutritional management of intestinal transplant recipients. (PubMedID: 7680149) Transplantation proceedings
02/01/1993
Monitoring and treatment of intestinal allograft rejection in humans. (PubMedID: 7680150) Transplantation proceedings
02/01/1993
Acute graft-versus-host-like disease induced by human CD56+, CD16+, CD8-dim+ cells in SCID mice. (PubMedID: 7680151) Transplantation proceedings
02/01/1993
Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantation. (PubMedID: 7680152) Transplantation proceedings
02/01/1993
Isolation of uninfected immature hematopoietic cells from bone marrow of simian immunodeficiency virus infected rhesus monkeys. (PubMedID: 7680153) Transplantation proceedings
02/01/1993
FK 506 in the management of nephrotic syndrome after renal transplantation. (PubMedID: 7680154) Transplantation proceedings
02/01/1993
Functional and histological evolution of the grafts after pediatric multiple abdominal viscera transplantation. (PubMedID: 7680155) Transplantation proceedings
02/01/1993
EBV human B-cell lymphomas in Scid mice: description of the model and study of the role of anti-CD40 and anti-CD23 monoclonal antibodies in their development. (PubMedID: 7680156) Transplantation proceedings
02/01/1993
Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection. (PubMedID: 7680157) Transplantation proceedings
02/01/1993
Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study. (PubMedID: 7680158) Transplantation proceedings
02/01/1993
Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up. (PubMedID: 7680159) Transplantation proceedings
02/01/1993
Liver disease and HCV infection after transplantation of organs from hepatitis C antibody positive donors. (PubMedID: 7680160) Transplantation proceedings
02/01/1993
Hepatitis C infection among renal transplant recipients: a comparative study using first- and second-generation anti-HCV EIA and HCV detection by nested PCR. (PubMedID: 7680161) Transplantation proceedings
02/01/1993
Value of a new four-antigen recombinant immunoblot assay in predicting recurrence of hepatitis C virus infection following liver transplantation. (PubMedID: 7680162) Transplantation proceedings
02/01/1993
Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival--a 5- and 10-year follow-up. (PubMedID: 7680163) Transplantation proceedings
02/01/1993
Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation. (PubMedID: 7680164) Transplantation proceedings
02/01/1993
Transmission of hepatitis C virus by renal transplantation. (PubMedID: 7680165) Transplantation proceedings
02/01/1993
Transmission of hepatitis C virus with solid organ transplantation: incidence and clinical significance. (PubMedID: 7680166) Transplantation proceedings
02/01/1993
Donor hepatitis C antibody virus testing in renal transplantation. (PubMedID: 7680167) Transplantation proceedings
02/01/1993
Successful canine small bowel preservation in simple cold storage for 48 hours using a dextran-40-based solution. (PubMedID: 7680168) Transplantation proceedings
02/01/1993
Human interleukin DA-1a (HILDA)/LIF,G-CSF, IL-1 beta, IL-6, and TNF alpha production during acute kidney graft rejection episodes. (PubMedID: 7680169) Transplantation proceedings
02/01/1993
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. (PubMedID: 7680170) Transplantation proceedings
02/01/1993
Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. (PubMedID: 7680171) Transplantation proceedings
02/01/1993
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. (PubMedID: 7680172) Transplantation proceedings
02/01/1993
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. (PubMedID: 7680173) Transplantation proceedings
02/01/1993
IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide. (PubMedID: 7680174) Transplantation proceedings
02/01/1993
The Jean Hamburger Memorial Congress. XIVth International Congress of the Transplantation Society. Proceedings. Paris, France, August 16-21, 1992. (PubMedID: 8094906) Transplantation proceedings
02/01/1993
Two-signal model for T-cell activation: molecular mechanisms. (PubMedID: 8094907) Transplantation proceedings
02/01/1993
Rapid and practical HLA class II genotyping by reverse dot blotting. (PubMedID: 8094908) Transplantation proceedings
02/01/1993
DNA typing of 3500 cadaver kidney transplants does not confirm the "DR6 effect". (PubMedID: 8094909) Transplantation proceedings
02/01/1993
HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center study. (PubMedID: 8094910) Transplantation proceedings
02/01/1993
Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies. (PubMedID: 8094911) Transplantation proceedings
02/01/1993
SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts. (PubMedID: 8094912) Transplantation proceedings
02/01/1993
Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production. (PubMedID: 8094913) Transplantation proceedings
02/01/1993
Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. (PubMedID: 8094914) Transplantation proceedings
02/01/1993
Clonal anergy induction by monoclonal antibodies to CD4, LFA-1, and ICAM-1. (PubMedID: 8094915) Transplantation proceedings
02/01/1993
Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. (PubMedID: 8094916) Transplantation proceedings
02/01/1993
Comparative immunosuppressive effect of anti-CD18 and anti-CD11a monoclonal antibodies on rat heart allotransplantation. (PubMedID: 8094917) Transplantation proceedings
02/01/1993
An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice. (PubMedID: 8094918) Transplantation proceedings
02/01/1993
Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation. (PubMedID: 8095106) Transplantation proceedings
02/01/1993
Polymerase chain reaction-DRB fingerprinting as a useful aid in the selection of HLA-matched unrelated bone marrow donors. (PubMedID: 8095107) Transplantation proceedings
02/01/1993
Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection. (PubMedID: 8095108) Transplantation proceedings
02/01/1993
Proceedings of the Jean Hamburger Memorial Congress. XIVth International Congress of the Transplantation Society. Paris, France, August 16-21, 1992. (PubMedID: 8095109) Transplantation proceedings
02/01/1993
Imaging of intercellular adhesion molecule-1 induction in rejecting heart: a new scintigraphic approach to detect early allograft rejection. (PubMedID: 8095110) Transplantation proceedings
02/01/1993
Relationship between intercellular adhesion molecule-1 and HLA class II expression in acute cellular rejection of human kidney allografts. (PubMedID: 8095111) Transplantation proceedings
02/01/1993
Does perforin mediate the direct injury of renal allograft in acute rejection? (PubMedID: 8095112) Transplantation proceedings
02/01/1993
Renal tubular cells express ICAM-1 during allograft rejection. (PubMedID: 8095113) Transplantation proceedings
02/01/1993
Circulating ICAM-1: novel parameter of renal graft rejection. (PubMedID: 8095114) Transplantation proceedings
02/01/1993
Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection. (PubMedID: 8095115) Transplantation proceedings
02/01/1993
Isolation of human minor histocompatibility peptides from cultured kidney cells. (PubMedID: 8382382) Transplantation proceedings
02/01/1993
Mechanisms responsible for inhibition of lymphocyte activation by agents which block membrane calcium or potassium channels. (PubMedID: 8382383) Transplantation proceedings
02/01/1993
T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection. (PubMedID: 8382384) Transplantation proceedings
02/01/1993
Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes. (PubMedID: 8382385) Transplantation proceedings
02/01/1993
Immunosuppression by delta opioid receptor antagonist. (PubMedID: 8382386) Transplantation proceedings
02/01/1993
New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients. (PubMedID: 8382847) Transplantation proceedings
02/01/1993
Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation? (PubMedID: 8382848) Transplantation proceedings
02/01/1993
Twenty-four years of orthotopic liver transplantation at Addenbrooke's Hospital, Cambridge. (PubMedID: 8382849) Transplantation proceedings
02/01/1993
Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. (PubMedID: 8382850) Transplantation proceedings
02/01/1993
Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. (PubMedID: 8382851) Transplantation proceedings
02/01/1993
Direct induction of class II antigens by cytomegalovirus in rat heart endothelial cells. (PubMedID: 8382852) Transplantation proceedings
02/01/1993
Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts. (PubMedID: 8382853) Transplantation proceedings
02/01/1993
Hypertension with combined pancreas-kidney transplants in patients with diabetic nephropathy. (PubMedID: 8382854) Transplantation proceedings
02/01/1993
Comparative effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine treatment on cytomegalovirus-induced interstitial pneumonitis in allogeneic bone marrow transplant recipient rats. (PubMedID: 8382855) Transplantation proceedings
02/01/1993
High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. (PubMedID: 8382856) Transplantation proceedings
02/01/1993
Acquired selective immunoglobulin A deficiency in renal transplant recipients. (PubMedID: 8382857) Transplantation proceedings
02/01/1993
Comparative study of adrenocortical function in renal transplant recipients under different long-term immunosuppressive therapy. (PubMedID: 8382858) Transplantation proceedings
02/01/1993
Viral and neoplastic changes of the lower genital tract in women with renal allografts. (PubMedID: 8382859) Transplantation proceedings
02/01/1993
Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants. (PubMedID: 8382860) Transplantation proceedings
02/01/1993
Skin malignancies and human papillomaviruses in renal transplant recipients. (PubMedID: 8382861) Transplantation proceedings
02/01/1993
Cytomegalovirus infection enhances allograft arteriosclerosis in the rat. (PubMedID: 8382862) Transplantation proceedings
02/01/1993
Meta-analysis of immune globulin prophylaxis in transplant recipients for the prevention of symptomatic cytomegalovirus disease. (PubMedID: 8382863) Transplantation proceedings
02/01/1993
Prospective study utilizing a quantitative polymerase chain reaction for detection of cytomegalovirus DNA in the blood of renal transplant patients. (PubMedID: 8382864) Transplantation proceedings
02/01/1993
Cytomegalovirus prophylaxis in pediatric renal transplant recipients. (PubMedID: 8382865) Transplantation proceedings
02/01/1993
Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. (PubMedID: 8382866) Transplantation proceedings
02/01/1993
Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease. (PubMedID: 8382867) Transplantation proceedings
02/01/1993
Cytomegalovirus infection in pediatric heart transplantation. (PubMedID: 8382868) Transplantation proceedings
02/01/1993
Quantitative immunodetection of cytomegalovirus antigenemia in the clinical diagnosis of CMV infection after heart transplantation. (PubMedID: 8382869) Transplantation proceedings
02/01/1993
Cytomegalovirus infection and prophylaxis in heart transplantation. (PubMedID: 8382870) Transplantation proceedings
02/01/1993
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study. (PubMedID: 8382871) Transplantation proceedings
02/01/1993
Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. (PubMedID: 8382872) Transplantation proceedings
02/01/1993
Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation. (PubMedID: 8382873) Transplantation proceedings
02/01/1993
Endothelial HLA class II induction mediated by allogeneic T cells activated by cytomegalovirus-infected cultured endothelial cells. (PubMedID: 8382874) Transplantation proceedings
02/01/1993
Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. (PubMedID: 8382875) Transplantation proceedings
02/01/1993
Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients. (PubMedID: 8382876) Transplantation proceedings
02/01/1993
Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival. (PubMedID: 8382877) Transplantation proceedings
02/01/1993
CD4 T-lymphocyte counts as predictors of pneumonia after kidney transplantation. (PubMedID: 8382878) Transplantation proceedings
02/01/1993
Leukocyte-endothelial interaction: effect of reactive metabolite scavenger. (PubMedID: 8382879) Transplantation proceedings
02/01/1993
Role of endothelium for tissue damage by active oxygen radicals in heart-lung transplantation. (PubMedID: 8382880) Transplantation proceedings
02/01/1993
Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. (PubMedID: 8382881) Transplantation proceedings
02/01/1993
Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study. (PubMedID: 8382882) Transplantation proceedings
02/01/1993
Expression of cytokines, growth factors, and their receptors in renal allograft biopsies. (PubMedID: 8382883) Transplantation proceedings
02/01/1993
Convocation. (PubMedID: 8438238) Transplantation proceedings
02/01/1993
Lysis of endothelial cells by graft-infiltrating lymphocytes after clinical heart transplantation. (PubMedID: 8438239) Transplantation proceedings
02/01/1993
CD4+ T-cell-dependent destruction of MHC class I disparate cardiac allografts. (PubMedID: 8438240) Transplantation proceedings
02/01/1993
Cytokines and transplantation. (PubMedID: 8438241) Transplantation proceedings
02/01/1993
Interleukin-2 receptor signal transduction: translocation of active serine-threonine kinase Raf-1 from IL-2 receptor into cytosol depends on IL-2-induced tyrosine kinase activation. (PubMedID: 8438242) Transplantation proceedings
02/01/1993
Cells infiltrating rejected human kidney allografts secrete IFN-gamma, IL-6, and IL-10, and are modulated by IL-2 and IL-4. (PubMedID: 8438243) Transplantation proceedings
02/01/1993
Cytokine mRNA expression during development of acute rejection in murine cardiac allografts. (PubMedID: 8438244) Transplantation proceedings
02/01/1993
Mixed lymphocyte kidney and islet cell cocultures: the effect of IFN-gamma and anti-IFN-gamma. (PubMedID: 8438245) Transplantation proceedings
02/01/1993
Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury. (PubMedID: 8438246) Transplantation proceedings
02/01/1993
Activation of lymphokine mRNA and protein synthesis in vivo in a murine graft-vs-host reaction. (PubMedID: 8438247) Transplantation proceedings
02/01/1993
Interleukin-2 antisense oligonucleotides inhibit T-cell function. (PubMedID: 8438248) Transplantation proceedings
02/01/1993
Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. (PubMedID: 8438249) Transplantation proceedings
02/01/1993
Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients. (PubMedID: 8438250) Transplantation proceedings
02/01/1993
Long-term storage of liver grafts is associated with a postoperative elevation of tumor necrosis factor: a possible role in the pathogenesis of primary nonfunction of the graft and pulmonary complications. (PubMedID: 8438251) Transplantation proceedings
02/01/1993
Role of HLA-DP antigen in xenogeneic iso-skin grafts using transgenic mice. (PubMedID: 8438252) Transplantation proceedings
02/01/1993
Antifection: a new method for targeted gene transfection. (PubMedID: 8438253) Transplantation proceedings
02/01/1993
Renal tubular cell expression of MHC class II (I-Eb) is insufficient to initiate immune injury in a transgenic kidney transplant model. (PubMedID: 8438254) Transplantation proceedings
02/01/1993
Loss of heparan sulfate proteoglycan as a manifestation of cellular immunity in vivo and in vitro. (PubMedID: 8438255) Transplantation proceedings
02/01/1993
Lymphocyte adhesion to allogeneic endothelium involves at least four different pathways. (PubMedID: 8438256) Transplantation proceedings
02/01/1993
Medawar Prize Lecture. Liver allo- and xenotransplantation. (PubMedID: 8438257) Transplantation proceedings
02/01/1993
Influence of oncogenes and cell metabolism on immunogenicity and tolerogenicity of a model macrophage cell line. (PubMedID: 8438258) Transplantation proceedings
02/01/1993
Modulation of ongoing antibody synthesis by antibody-coated platelets in the rat: opposite effects of antibody classes. (PubMedID: 8438259) Transplantation proceedings
02/01/1993
HLA, anthropology, and transplantation. (PubMedID: 8438260) Transplantation proceedings
02/01/1993
Diversity in mRNA encoding soluble form MHC class I-like molecules in human renal tissues. (PubMedID: 8438261) Transplantation proceedings
02/01/1993
HLA 1992: typing strategies and perspectives in bone marrow transplantation. (PubMedID: 8438262) Transplantation proceedings
02/01/1993
Revisiting HLA matching for kidney transplantation. (PubMedID: 8438263) Transplantation proceedings
02/01/1993
Workshop report: clinical relevance of new crossmatching techniques. (PubMedID: 8438264) Transplantation proceedings
02/01/1993
Sequence-specific interactions of the nuclear proteins with polymorphic upstream regulatory regions of HLA-DRB genes. (PubMedID: 8438265) Transplantation proceedings
02/01/1993
Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. (PubMedID: 8438266) Transplantation proceedings
02/01/1993
Molecular characterization of endothelial cell antigens involved in renal allograft rejection. (PubMedID: 8438267) Transplantation proceedings
02/01/1993
T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection. (PubMedID: 8438268) Transplantation proceedings
02/01/1993
A simple and practical test of HLA-DRB and -DQB matching in transplantation. (PubMedID: 8438269) Transplantation proceedings
02/01/1993
Polymerase chain reaction-single-strand conformation polymorphism analysis of HLA-DP genes and its application in transplantation. (PubMedID: 8438270) Transplantation proceedings
02/01/1993
Efficacy of sequence-specific oligotyping in determining HLA-DR compatibility in cadaver kidney transplantation. The North Italy Transplant Program Working Group on Improvement of Kidney Transplantation. (PubMedID: 8438271) Transplantation proceedings
02/01/1993
The transplantation society meeting in Paris. (PubMedID: 8438272) Transplantation proceedings
02/01/1993
HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy. (PubMedID: 8438273) Transplantation proceedings
02/01/1993
Does previous breast feeding affect maternal donor renal allograft outcome? A single-institution experience. (PubMedID: 8438274) Transplantation proceedings
02/01/1993
Effect of reexposure to mismatched major histocompatibility complex antigens on renal retransplant allograft survival. (PubMedID: 8438275) Transplantation proceedings
02/01/1993
Reduction of the center effect by HLA matching. (PubMedID: 8438276) Transplantation proceedings
02/01/1993
Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing. (PubMedID: 8438277) Transplantation proceedings
02/01/1993
Significance of HLA-DR matching at the DNA level in clinical renal transplantation. (PubMedID: 8438278) Transplantation proceedings
02/01/1993
HLA-B mismatch: an equally strong prognostic factor for kidney transplantation when compared with HLA-DR mismatch. (PubMedID: 8438279) Transplantation proceedings
02/01/1993
Role of donor-recipient HLA disparity in the development of humoral immune reactions in corneal transplantation. (PubMedID: 8438280) Transplantation proceedings
02/01/1993
Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure? (PubMedID: 8438281) Transplantation proceedings
02/01/1993
Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. (PubMedID: 8438282) Transplantation proceedings
02/01/1993
Effects of DR mismatch on long-term graft survival in simultaneous kidney-pancreas transplantation. (PubMedID: 8438283) Transplantation proceedings
02/01/1993
HLA-A2-specific antibody production in severe combined immunodeficient mice reconstituted with human peripheral blood leukocytes from HLA-presensitized donors. (PubMedID: 8438284) Transplantation proceedings
02/01/1993
Delayed elimination of donor red blood cells is associated with host major histocompatibility complex and donor-specific blood transfusion enhancement of rat renal allograft survival. (PubMedID: 8438285) Transplantation proceedings
02/01/1993
Anti-HLA antibodies: detection and effect on renal transplant function. (PubMedID: 8438286) Transplantation proceedings
02/01/1993
Flow cytometry crossmatching for kidney transplantation. (PubMedID: 8438287) Transplantation proceedings
02/01/1993
Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation. (PubMedID: 8438288) Transplantation proceedings
02/01/1993
Xenotransplantation: a view to the future. (PubMedID: 8438289) Transplantation proceedings
02/01/1993
Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients. (PubMedID: 8438290) Transplantation proceedings
02/01/1993
Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. (PubMedID: 8438291) Transplantation proceedings
02/01/1993
Strategy for improving retransplantation in the CyA era. (PubMedID: 8438292) Transplantation proceedings
02/01/1993
Value of flow cytometric monitoring of posttransplant antibody status in renal transplantation. (PubMedID: 8438293) Transplantation proceedings
02/01/1993
Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. (PubMedID: 8438294) Transplantation proceedings
02/01/1993
Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team. (PubMedID: 8438295) Transplantation proceedings
02/01/1993
Crossing the ABO blood barrier in renal transplantation. (PubMedID: 8438296) Transplantation proceedings
02/01/1993
ABO-incompatible kidney transplantation in a single-center trial. (PubMedID: 8438297) Transplantation proceedings
02/01/1993
Local immune states in ABO-incompatible renal allografts. (PubMedID: 8438298) Transplantation proceedings
02/01/1993
Induction of tolerance in immature and mature T cells. (PubMedID: 8438299) Transplantation proceedings
02/01/1993
Anergy in allogeneic transplantation. (PubMedID: 8438300) Transplantation proceedings
02/01/1993
Intrathymic islet allografts prevent hyperglycemia and autoimmune beta-cell destruction in BB rats following transplantation in the prediabetic period. (PubMedID: 8438301) Transplantation proceedings
02/01/1993
Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection. (PubMedID: 8438302) Transplantation proceedings
02/01/1993
Medullary thymic epithelium induces tolerance to allogeneic major histocompatibility complex class I antigens. (PubMedID: 8438303) Transplantation proceedings
02/01/1993
Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells. (PubMedID: 8438304) Transplantation proceedings
02/01/1993
Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes. (PubMedID: 8438305) Transplantation proceedings
02/01/1993
Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes. (PubMedID: 8438306) Transplantation proceedings
02/01/1993
Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities. (PubMedID: 8438307) Transplantation proceedings
02/01/1993
Induction of specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor major histocompatibility complex class I antigens. (PubMedID: 8438308) Transplantation proceedings
02/01/1993
Knock-out mice: a new tool for transplantation immunologists. (PubMedID: 8438309) Transplantation proceedings
02/01/1993
Intrathymic inoculation of islets at birth prevents autoimmune diabetes and pancreatic insulitis in the BB rat. (PubMedID: 8438310) Transplantation proceedings
02/01/1993
Intrathymic injection of donor antigen-presenting cells prolongs heart graft survival. (PubMedID: 8438311) Transplantation proceedings
02/01/1993
Donor antigen-specific T-lymphocyte deletion after intrathymic inoculation. (PubMedID: 8438312) Transplantation proceedings
02/01/1993
Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model. (PubMedID: 8438313) Transplantation proceedings
02/01/1993
Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. (PubMedID: 8438314) Transplantation proceedings
02/01/1993
Decreased IFN-gamma and IL-2 mRNA expression in peripheral tolerance to heart allografts with conserved granzyme A, perforin, and MHC antigens mRNA expression. (PubMedID: 8438315) Transplantation proceedings
02/01/1993
Role of interferon-gamma in the induction of clonal deletion after injection of staphylococcal enterotoxin B. (PubMedID: 8438316) Transplantation proceedings
02/01/1993
Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts. (PubMedID: 8438317) Transplantation proceedings
02/01/1993
Interleukin-2 reverses the ability of cyclosporine to induce tolerance to class I disparate kidney allografts in miniature swine. (PubMedID: 8438318) Transplantation proceedings
02/01/1993
Th2-like effectors may function as antigen-specific suppressor cells in states of transplantation tolerance. (PubMedID: 8438319) Transplantation proceedings
02/01/1993
Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism. (PubMedID: 8438320) Transplantation proceedings
02/01/1993
Mechanism of allograft tolerance in nonhuman primates: purification of a specific isotype of IgG with suppressor activity. (PubMedID: 8438321) Transplantation proceedings
02/01/1993
Body parts: the modern dilemma. (PubMedID: 8438322) Transplantation proceedings
02/01/1993
Thy 1+ donor cells function as veto cells in the maintenance of tolerance across a major histocompatibility complex disparity in mixed-lymphoid radiation chimeras. (PubMedID: 8438323) Transplantation proceedings
02/01/1993
Persistence of donor-reactive T cells after liver transplantation-induced tolerance in mice. (PubMedID: 8438324) Transplantation proceedings
02/01/1993
Xenotransplantation from pig to cynomolgus monkey: approach toward tolerance induction. (PubMedID: 8438325) Transplantation proceedings
02/01/1993
Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival. (PubMedID: 8438326) Transplantation proceedings
02/01/1993
Effect of depleting CD3+ cells from DR- donor bone marrow to facilitate kidney graft tolerance in recipients given total lymphoid irradiation. (PubMedID: 8438327) Transplantation proceedings
02/01/1993
Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog. (PubMedID: 8438328) Transplantation proceedings
02/01/1993
Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene. (PubMedID: 8438329) Transplantation proceedings
02/01/1993
In vitro and in vivo activities of long-term cultured veto suppressor clones. (PubMedID: 8438330) Transplantation proceedings
02/01/1993
Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens. (PubMedID: 8438331) Transplantation proceedings
02/01/1993
Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells. (PubMedID: 8438332) Transplantation proceedings
02/01/1993
Induction of immunity and oral tolerance to alloantigen by polymorphic class II major histocompatibility complex allopeptides in the rat. (PubMedID: 8438333) Transplantation proceedings
02/01/1993
Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo. (PubMedID: 8438334) Transplantation proceedings
02/01/1993
Anti-V beta TcR monoclonal antibodies identify and can activate anergic T cells from mice rendered neonatally tolerant of class II alloantigens. (PubMedID: 8438335) Transplantation proceedings
02/01/1993
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. (PubMedID: 8438336) Transplantation proceedings
02/01/1993
Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences. (PubMedID: 8438337) Transplantation proceedings
02/01/1993
Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice. (PubMedID: 8438338) Transplantation proceedings
02/01/1993
Alterations in peripheral V beta 11+ T-cell populations are not predictive of allograft rejection in I-E- mice resistant to neonatal tolerance induction. (PubMedID: 8438339) Transplantation proceedings
02/01/1993
Continued presence of donor leukocytes in recipients of liver grafts. (PubMedID: 8438340) Transplantation proceedings
02/01/1993
Donor-specific tolerance induced by non-major histocompatibility complex disparate kidney grafts for subsequent pancreas transplants. (PubMedID: 8438341) Transplantation proceedings
02/01/1993
Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. (PubMedID: 8438342) Transplantation proceedings
02/01/1993
Study of the target antigens of hyperacute xenogeneic rejection in discordant combinations. (PubMedID: 8438343) Transplantation proceedings
02/01/1993
Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. (PubMedID: 8438344) Transplantation proceedings
02/01/1993
Long-term survival of xenogeneic skin grafts in widely disparate combinations. (PubMedID: 8438345) Transplantation proceedings
02/01/1993
Depletion of preformed antibody in primates for discordant xenotransplantation by continuous donor organ plasma perfusion. (PubMedID: 8438346) Transplantation proceedings
02/01/1993
Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers. (PubMedID: 8438347) Transplantation proceedings
02/01/1993
Relationship between human natural anti-A, anti-B alloantibodies and anti-pig xenoantibodies. (PubMedID: 8438348) Transplantation proceedings
02/01/1993
Consent for organ donation: what are the ethical principles? (PubMedID: 8438349) Transplantation proceedings
02/01/1993
Characterization of human antibodies that are cytotoxic to pig aortic endothelial cells. (PubMedID: 8438350) Transplantation proceedings
02/01/1993
CD46 (MCP) confers protection from lysis by xenogeneic antibodies. (PubMedID: 8438351) Transplantation proceedings
02/01/1993
Complement depletion prolongs discordant cardiac xenograft survival in rodents and non-human primates. (PubMedID: 8438352) Transplantation proceedings
02/01/1993
Dedication of the XIVth International Congress of the Transplantation Society--the Jean Hamburger Memorial Congress--and citations. (PubMedID: 8438353) Transplantation proceedings
02/01/1993
Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation. (PubMedID: 8438354) Transplantation proceedings
02/01/1993
Effectiveness of combination therapy using cobra venom factor, splenectomy, and deoxyspergualin in guinea pig to rat cardiac xenografts. (PubMedID: 8438355) Transplantation proceedings
02/01/1993
Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor. (PubMedID: 8438356) Transplantation proceedings
02/01/1993
Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts. (PubMedID: 8438357) Transplantation proceedings
02/01/1993
Deoxyspergualin and rabbit antithymocyte globulin markedly prolong discordant pig pancreatic islet xenografts. (PubMedID: 8438358) Transplantation proceedings
02/01/1993
Long-term suppression of natural and graft-induced xenophile antibodies by short-term antigen-cyclophosphamide treatment. (PubMedID: 8438359) Transplantation proceedings
02/01/1993
Splenectomy is a potent immunosuppressive modality for cardiac xenografting. (PubMedID: 8438360) Transplantation proceedings
02/01/1993
Alternative sources of clinically transplantable vital organs. (PubMedID: 8438361) Transplantation proceedings
02/01/1993
Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate. (PubMedID: 8438362) Transplantation proceedings
02/01/1993
Effects of cholera toxin in xenograft survival. (PubMedID: 8438363) Transplantation proceedings
02/01/1993
Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay. (PubMedID: 8438364) Transplantation proceedings
02/01/1993
Continuous administration of methyldeoxyspergualin prolongs xenograft survival in hamster-to-rat cardiac transplantation. (PubMedID: 8438365) Transplantation proceedings
02/01/1993
Modulation of acute and hyperacute rejection of xenografts in concordant hamster-to-rat combination. (PubMedID: 8438366) Transplantation proceedings
02/01/1993
Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken. (PubMedID: 8438367) Transplantation proceedings
02/01/1993
Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse). (PubMedID: 8438368) Transplantation proceedings
02/01/1993
Xenoreactive T-cell lines initiate pancreatic islet graft destruction in vivo. (PubMedID: 8438369) Transplantation proceedings
02/01/1993
Human antiporcine mixed lymphocyte reaction. (PubMedID: 8438370) Transplantation proceedings
02/01/1993
Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. (PubMedID: 8438371) Transplantation proceedings
02/01/1993
Allogeneic and xenogeneic cross-reactions in hyperimmune recipients. (PubMedID: 8438372) Transplantation proceedings
02/01/1993
Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft. (PubMedID: 8438373) Transplantation proceedings
02/01/1993
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies. (PubMedID: 8438374) Transplantation proceedings
02/01/1993
Long-term chimera produced by transplantation of human fetal liver cells into severe combined immunodeficiency mice. (PubMedID: 8438375) Transplantation proceedings
02/01/1993
Effect of primary xenograft or allograft on the rejection of a subsequent allograft. (PubMedID: 8438376) Transplantation proceedings
02/01/1993
Xenoreactivity in mouse + rat-->mouse chimeras. (PubMedID: 8438377) Transplantation proceedings
02/01/1993
Xenogeneic orthotopic liver transplantation in nonhuman primates. (PubMedID: 8438378) Transplantation proceedings
02/01/1993
Humoral reaction to microencapsulated rat, canine, and porcine islet xenografts in spontaneously diabetic NOD mice. (PubMedID: 8438379) Transplantation proceedings
02/01/1993
Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models. (PubMedID: 8438380) Transplantation proceedings
02/01/1993
Drug development and testing in relation to cell migration and chimerism. (PubMedID: 8438381) Transplantation proceedings
02/01/1993
Is there a need for pancreas transplantation? Pro. (PubMedID: 8438382) Transplantation proceedings
02/01/1993
Therapeutic monoclonal antibodies in transplantation. (PubMedID: 8438383) Transplantation proceedings
02/01/1993
Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells. (PubMedID: 8438384) Transplantation proceedings
02/01/1993
Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. (PubMedID: 8438385) Transplantation proceedings
02/01/1993
Specificity of donor bone marrow cells that abrogate second-set allograft rejection. (PubMedID: 8438386) Transplantation proceedings
02/01/1993
Peptide from one of the alpha helical regions of H-2Kb can manipulate responses to the H-2Kb alloantigen in vitro and in vivo. (PubMedID: 8438387) Transplantation proceedings
02/01/1993
Peptides corresponding to the CD8 binding region of HLA class I block the differentiation of cytotoxic T lymphocyte precursors. (PubMedID: 8438388) Transplantation proceedings
02/01/1993
Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. (PubMedID: 8438389) Transplantation proceedings
02/01/1993
Intrathymic inoculation of donor cells promotes survival of rat orthotopic liver allografts. (PubMedID: 8438390) Transplantation proceedings
02/01/1993
Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation. (PubMedID: 8438391) Transplantation proceedings
02/01/1993
Selective changes in human T-cell receptor repertoire after blood transfusion. (PubMedID: 8438392) Transplantation proceedings
02/01/1993
Ex vivo perfusion of the cluster graft with anti-class II antibody can significantly prevent acute rejection in swine abdominal organ cluster transplantation. (PubMedID: 8438393) Transplantation proceedings
02/01/1993
Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells. (PubMedID: 8438394) Transplantation proceedings
02/01/1993
Ten years' experience with cyclosporine monotherapy after renal transplantation. (PubMedID: 8438395) Transplantation proceedings
02/01/1993
Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA? (PubMedID: 8438396) Transplantation proceedings
02/01/1993
Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay. (PubMedID: 8438397) Transplantation proceedings
02/01/1993
Is there a need for pancreas transplantation? Con. (PubMedID: 8438398) Transplantation proceedings
02/01/1993
Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor. (PubMedID: 8438399) Transplantation proceedings
02/01/1993
Nuclear membrane-associated cyclophilins of potential importance in cyclosporine immunosuppression. (PubMedID: 8438400) Transplantation proceedings
02/01/1993
European multicentre trial of cyclosporine in renal transplantation: 10-year follow-up. (PubMedID: 8438401) Transplantation proceedings
02/01/1993
Effect of cyclosporine on chronic vascular rejection in an inbred rat cardiac model. (PubMedID: 8438402) Transplantation proceedings
02/01/1993
Temporary immunosuppression for peripheral nerve allografts. (PubMedID: 8438403) Transplantation proceedings
02/01/1993
Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts. (PubMedID: 8438404) Transplantation proceedings
02/01/1993
TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival. (PubMedID: 8438405) Transplantation proceedings
02/01/1993
Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection. (PubMedID: 8438406) Transplantation proceedings
02/01/1993
Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules. (PubMedID: 8438407) Transplantation proceedings
02/01/1993
Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups? (PubMedID: 8438408) Transplantation proceedings
02/01/1993
Regulated commercialism of vital organ donation: a necessity? Con. (PubMedID: 8438409) Transplantation proceedings
02/01/1993
Results of a prospective, randomized double-blind study comparing standard vs low-dose OKT3 induction therapy. (PubMedID: 8438410) Transplantation proceedings
02/01/1993
Low-dose OKT3 induction therapy following renal transplantation leads to improved graft function and decreased adverse effects. (PubMedID: 8438411) Transplantation proceedings
02/01/1993
OKT3 prophylaxis in liver transplant patients: a European and Australian multicenter, prospective controlled trial. (PubMedID: 8438412) Transplantation proceedings
02/01/1993
OKT3 antibody response study (OARS): a multicenter comparative study. (PubMedID: 8438413) Transplantation proceedings
02/01/1993
Suppression of OKT3-induced tumor necrosis factor alpha formation by pentoxifylline in renal transplant recipients. (PubMedID: 8438414) Transplantation proceedings
02/01/1993
Cytokine-related encephalopathy induced by OKT3: incidence and predisposing factors. (PubMedID: 8438415) Transplantation proceedings
02/01/1993
Activation of coagulation and fibrinolysis during treatment with OKT3. (PubMedID: 8438416) Transplantation proceedings
02/01/1993
In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice. (PubMedID: 8438417) Transplantation proceedings
02/01/1993
Prophylactic OKT3 monoclonal antibody versus antilymphocyte globulins: a prospective, randomized study in 148 first cadaver kidney grafts. (PubMedID: 8438418) Transplantation proceedings
02/01/1993
Morbidity of intraoperative OKT3 administration in primary cadaveric renal transplant recipients. (PubMedID: 8438419) Transplantation proceedings
02/01/1993
Is the routine use of induction immunosuppression with ALG or OKT3 justified in cadaveric renal transplantation? (PubMedID: 8438420) Transplantation proceedings
02/01/1993
Association of sensitization to horse antilymphocyte/thymocyte globulin with recipient age and decreased renal allograft survival rates. (PubMedID: 8438421) Transplantation proceedings
02/01/1993
Regulated commercialism in transplantation: the factitious focus. (PubMedID: 8438422) Transplantation proceedings
02/01/1993
Initiation of ALG pretransplant reduces the incidence of delayed renal allograft function. (PubMedID: 8438423) Transplantation proceedings
02/01/1993
Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee. (PubMedID: 8438424) Transplantation proceedings
02/01/1993
Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function. (PubMedID: 8438425) Transplantation proceedings
02/01/1993
Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy. (PubMedID: 8438426) Transplantation proceedings
02/01/1993
Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression. (PubMedID: 8438427) Transplantation proceedings
02/01/1993
Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial. (PubMedID: 8438428) Transplantation proceedings
02/01/1993
Predictors of improved outcome in second pediatric renal transplant recipients. (PubMedID: 8438429) Transplantation proceedings
02/01/1993
A futures market in cadaveric organs: would it work? (PubMedID: 8438430) Transplantation proceedings
02/01/1993
Renal transplantation: nifedipine for the nonstarters? A prospective randomised study. (PubMedID: 8438431) Transplantation proceedings
02/01/1993
Misoprostol in renal transplantation. (PubMedID: 8438432) Transplantation proceedings
02/01/1993
Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. (PubMedID: 8438433) Transplantation proceedings
02/01/1993
Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival. (PubMedID: 8438434) Transplantation proceedings
02/01/1993
Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients. (PubMedID: 8438435) Transplantation proceedings
02/01/1993
Influence of posttransplantation blood transfusion on kidney allograft survival: a one-center, double-blind, prospective, randomized study comparing cryopreserved and fresh red blood cell concentrates. (PubMedID: 8438436) Transplantation proceedings
02/01/1993
Adhesion and homing molecules. (PubMedID: 8438437) Transplantation proceedings
02/01/1993
Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report. (PubMedID: 8438438) Transplantation proceedings
02/01/1993
New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation. (PubMedID: 8438439) Transplantation proceedings
02/01/1993
One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation. (PubMedID: 8438440) Transplantation proceedings
02/01/1993
Controlled trial of RS-61443 in renal transplant patients receiving cyclosporine monotherapy. (PubMedID: 8438441) Transplantation proceedings
02/01/1993
RS-61443 for treatment-resistant human liver rejection. (PubMedID: 8438442) Transplantation proceedings
02/01/1993
RS-61443: rescue therapy in refractory kidney transplant rejection. (PubMedID: 8438443) Transplantation proceedings
02/01/1993
Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785). (PubMedID: 8438444) Transplantation proceedings
02/01/1993
RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival. (PubMedID: 8438445) Transplantation proceedings
02/01/1993
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. (PubMedID: 8438446) Transplantation proceedings
02/01/1993
Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat. (PubMedID: 8438447) Transplantation proceedings
02/01/1993
Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium. (PubMedID: 8438448) Transplantation proceedings
02/01/1993
Effects of brequinar sodium on cynomolgus monkeys: immunosuppression and pharmacokinetics. (PubMedID: 8438449) Transplantation proceedings
02/01/1993
Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts. (PubMedID: 8438450) Transplantation proceedings
02/01/1993
Influence of rat strain on rapamycin's kidney effects. (PubMedID: 8438451) Transplantation proceedings
02/01/1993
Rapamycin in a porcine renal transplant model. (PubMedID: 8438452) Transplantation proceedings
02/01/1993
Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice. (PubMedID: 8438453) Transplantation proceedings
02/01/1993
Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat. (PubMedID: 8438454) Transplantation proceedings
02/01/1993
Studies of the T-cell receptors of T cells recognizing the same HLA molecule. (PubMedID: 8438455) Transplantation proceedings
02/01/1993
Rapamycin's long-term effects on humoral and cellular immune responses in the rat. (PubMedID: 8438456) Transplantation proceedings
02/01/1993
In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model. (PubMedID: 8438457) Transplantation proceedings
02/01/1993
Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation. (PubMedID: 8438458) Transplantation proceedings
02/01/1993
Rapamycin effects on immunologic reconstitution. (PubMedID: 8438459) Transplantation proceedings
02/01/1993
Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection. (PubMedID: 8438460) Transplantation proceedings
02/01/1993
T-cell alloreactivity to major histocompatibility complex peptides in context of self major histocompatibility complex. (PubMedID: 8438461) Transplantation proceedings
02/01/1993
Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients. (PubMedID: 8438462) Transplantation proceedings
02/01/1993
Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor. (PubMedID: 8438463) Transplantation proceedings
02/01/1993
Interference with intracellular carbohydrate processing by castanospermine prolongs heart allograft survival. (PubMedID: 8438464) Transplantation proceedings
02/01/1993
Immunosuppressive effects of leflunomide in a cardiac allograft model. (PubMedID: 8438465) Transplantation proceedings
02/01/1993
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression. (PubMedID: 8438466) Transplantation proceedings
02/01/1993
Analysis of T-cell receptor V beta gene usage in T cells infiltrating human renal allografts. (PubMedID: 8438467) Transplantation proceedings
02/01/1993
Effects of rapamycin on renal microsomal P-450 systems in the rat. (PubMedID: 8438468) Transplantation proceedings
02/01/1993
Effects of immunosuppressive therapy on the rat aortic allograft model. (PubMedID: 8438469) Transplantation proceedings
02/01/1993
DAB486-IL-2 (IL-2-toxin) in combination with low-dose RS-61443 (mycophenolate mofetil) prolongs murine thyroid allograft survival. (PubMedID: 8438470) Transplantation proceedings
02/01/1993
Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts. (PubMedID: 8438471) Transplantation proceedings
02/01/1993
Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative. (PubMedID: 8438472) Transplantation proceedings
02/01/1993
15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model. (PubMedID: 8438473) Transplantation proceedings
02/01/1993
T-cell receptor V gene segment usage of graft-infiltrating T-lymphocytes after heart transplantation. (PubMedID: 8438474) Transplantation proceedings
02/01/1993
Further study of deoxyspergualin prophylaxis in living related renal transplantation. (PubMedID: 8438475) Transplantation proceedings
02/01/1993
Generation of a potentially immunosuppressive rat interleukin-2 immunoglobulin M fusion molecule. (PubMedID: 8438476) Transplantation proceedings
02/01/1993
Eight-year actuarial graft and patient survival of kidney transplants in highly immunized recipients pretreated with total lymphoid irradiation: a single-center experience. (PubMedID: 8438477) Transplantation proceedings
02/01/1993
15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation. (PubMedID: 8438478) Transplantation proceedings
02/01/1993
Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies. (PubMedID: 8438479) Transplantation proceedings
02/01/1993
Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation. (PubMedID: 8438480) Transplantation proceedings
02/01/1993
Selection and chimerization of a monoclonal CD4 antibody for heart transplantation. (PubMedID: 8438481) Transplantation proceedings
02/01/1993
Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments. (PubMedID: 8438482) Transplantation proceedings
02/01/1993
Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice. (PubMedID: 8438483) Transplantation proceedings
02/01/1993
Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival. (PubMedID: 8438484) Transplantation proceedings
02/01/1993
Anti-T cell monoclonal antibodies for immunosuppression in xenotransplantation of fetal pig pancreas in NOD mice. (PubMedID: 8438485) Transplantation proceedings
02/01/1993
Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection. (PubMedID: 8438486) Transplantation proceedings
02/01/1993
Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction. (PubMedID: 8438487) Transplantation proceedings
02/01/1993
Differential expression of T-cell receptor-V region determinants on infiltrating T cells in rejecting and nonrejecting human kidney, liver, and heart allografts. (PubMedID: 8438488) Transplantation proceedings
02/01/1993
OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics. (PubMedID: 8438489) Transplantation proceedings
02/01/1993
Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience. (PubMedID: 8438490) Transplantation proceedings
02/01/1993
CD4 monoclonal antibodies in the preclinical dog renal allograft model. (PubMedID: 8438491) Transplantation proceedings
02/01/1993
Differential sensitivity to anti-LFA-1 inhibition of Th1 vs Th2 anti-minor histocompatibility antigen immune T cells after restimulation with antigen on hepatic or splenic APCs. (PubMedID: 8438492) Transplantation proceedings
02/01/1993
A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts. (PubMedID: 8438493) Transplantation proceedings
02/01/1993
Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts. (PubMedID: 8438494) Transplantation proceedings
02/01/1993
Chemically engineered bispecific antibody directed at the p55 and p75 chains of the human interleukin 2 receptor: specific high-affinity cross-linking of p55/p75 complexes and high blocking effect on IL2-induced T cell proliferation. (PubMedID: 8438495) Transplantation proceedings
02/01/1993
Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study. (PubMedID: 8438496) Transplantation proceedings
02/01/1993
Generation of rabbit anti-lymphocyte monoclonal antibodies. (PubMedID: 8438497) Transplantation proceedings
02/01/1993
T-cell receptor-V alpha gene use in sequential liver allograft biopsies. (PubMedID: 8438498) Transplantation proceedings
02/01/1993
Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches. (PubMedID: 8438499) Transplantation proceedings
02/01/1993
Conceptual aspects of antigen presentation across a species barrier. (PubMedID: 8438500) Transplantation proceedings
02/01/1993
H-2 class I-restricted recognition of allogeneic class I peptides. (PubMedID: 8438501) Transplantation proceedings
02/01/1993
Major histocompatibility complex-expressing human cardiac myocytes are not the direct target of host cardiac-infiltrating cells: evidence for a prominent role of the indirect pathway in human cardiac allograft rejection. (PubMedID: 8438502) Transplantation proceedings
02/01/1993
Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction. (PubMedID: 8438503) Transplantation proceedings
02/01/1993
Passenger leukocyte effect not mediated by interstitial dendritic cells. (PubMedID: 8438504) Transplantation proceedings
02/01/1993
Lymphocyte culture from routine endomyocardial biopsies: lack of clinical or pathological correlations. (PubMedID: 8438505) Transplantation proceedings
02/01/1993
Transplantation of genetically altered hepatocytes using cell-polymer constructs. (PubMedID: 8442022) Transplantation proceedings
02/01/1993
Neural transplants in Parkinson's disease. CPH Neural Transplantation Group. (PubMedID: 8442023) Transplantation proceedings
02/01/1993
Transplantation of fetal liver stem cells into patients and into human fetuses, with induction of immunologic tolerance. (PubMedID: 8442024) Transplantation proceedings
02/01/1993
Hepatocyte transplantation into spleen or solid supports: comparison of morphology, function, and proliferative response. (PubMedID: 8442025) Transplantation proceedings
02/01/1993
Transplantation of allogeneic retinal pigment epithelium under the kidney capsule. (PubMedID: 8442026) Transplantation proceedings
02/01/1993
Tissue-engineered growth of bone and cartilage. (PubMedID: 8442027) Transplantation proceedings
02/01/1993
Allospecific suppressive effect of TcR-alpha beta +CD4-8- T cells in the livers of mice inoculated with allogeneic cells via the portal vein. (PubMedID: 8442028) Transplantation proceedings
02/01/1993
Enalapril: safe and effective therapy for posttransplant erythrocytosis. (PubMedID: 8442029) Transplantation proceedings
02/01/1993
Reversal of myocardial dysfunction following renal transplantation. (PubMedID: 8442030) Transplantation proceedings
02/01/1993
National Transplantation Pregnancy Registry: analysis of pregnancy outcomes of female kidney recipients with relation to time interval from transplant to conception. (PubMedID: 8442031) Transplantation proceedings
02/01/1993
Successful percutaneous treatment of ureteral stenosis after renal transplantation. (PubMedID: 8442032) Transplantation proceedings
02/01/1993
Match prognostic index for predicting waiting time to renal transplantation. (PubMedID: 8442033) Transplantation proceedings
02/01/1993
Prognostic factors of hemolytic uremic syndrome in renal allografts. (PubMedID: 8442034) Transplantation proceedings
02/01/1993
HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation. (PubMedID: 8442035) Transplantation proceedings
02/01/1993
Impact of obesity on renal transplantation. (PubMedID: 8442036) Transplantation proceedings
02/01/1993
Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian study group. (PubMedID: 8442037) Transplantation proceedings
02/01/1993
Hypercoagulable state as a risk factor in transplantation. (PubMedID: 8442038) Transplantation proceedings
02/01/1993
Comparative analysis of concurrent urine cytology and kidney aspirate in the rapid assessment of acute allograft dysfunction. (PubMedID: 8442039) Transplantation proceedings
02/01/1993
Optimizing kidney perfusion with anti-CD45 monoclonal antibody. (PubMedID: 8442040) Transplantation proceedings
02/01/1993
Impact of vesicoureteral reflux on graft survival in renal transplantation. (PubMedID: 8442041) Transplantation proceedings
02/01/1993
Abnormal lipid and lipoprotein profiles following renal transplantation. (PubMedID: 8442042) Transplantation proceedings
02/01/1993
Renal transplantation in elderly patients: survival and complications. (PubMedID: 8442043) Transplantation proceedings
02/01/1993
Rapidly rising pretransplant hematocrit and hematocrit > or = 30% signal independent risks for delayed function and primary nonfunction in primary cadaveric renal transplantation. (PubMedID: 8442044) Transplantation proceedings
02/01/1993
Liver transplantation in newborn liver failure: treatment for neonatal hemochromatosis. (PubMedID: 8442045) Transplantation proceedings
02/01/1993
Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation. (PubMedID: 8442046) Transplantation proceedings
02/01/1993
Liver transplantation in patients beyond age 60. (PubMedID: 8442047) Transplantation proceedings
02/01/1993
Hepatic retransplantation: the Hannover experience of two decades. (PubMedID: 8442048) Transplantation proceedings
02/01/1993
Safety and operative stress for donors in living-related partial liver transplantation. (PubMedID: 8442049) Transplantation proceedings
02/01/1993
Liver transplantation in children from living-related donors. (PubMedID: 8442050) Transplantation proceedings
02/01/1993
Results with percutaneous transjugular intrahepatic portosystemic stent-shunts for control of variceal hemorrhage in patients awaiting liver transplantation. (PubMedID: 8442051) Transplantation proceedings
02/01/1993
Management of emergencies before and after liver transplantation by early total hepatectomy. (PubMedID: 8442052) Transplantation proceedings
02/01/1993
Use of cryopreserved vein allogeneic homografts in liver transplantation. (PubMedID: 8442053) Transplantation proceedings
02/01/1993
Hepatic artery reconstruction under microvascular surgery in partial liver transplantation from living donor. (PubMedID: 8442054) Transplantation proceedings
02/01/1993
Partial hepatic resection following liver transplantation. (PubMedID: 8442055) Transplantation proceedings
02/01/1993
Hepatic vein reconstruction in pediatric living donor liver transplantation: an overview of a series of 30 cases. (PubMedID: 8442056) Transplantation proceedings
02/01/1993
Transplantation of small donor livers in adult recipients. (PubMedID: 8442057) Transplantation proceedings
02/01/1993
Clinical outcome of ischemic-type biliary complications after liver transplantation. (PubMedID: 8442058) Transplantation proceedings
02/01/1993
Capillarization of the hepatic sinusoid in failed liver grafts. (PubMedID: 8442059) Transplantation proceedings
02/01/1993
Late graft loss after liver transplantation: a study of 434 consecutive patients. (PubMedID: 8442060) Transplantation proceedings
02/01/1993
Early outcome of liver transplantation in patients with a history of spontaneous bacterial peritonitis. (PubMedID: 8442061) Transplantation proceedings
02/01/1993
Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score. (PubMedID: 8442062) Transplantation proceedings
02/01/1993
Spontaneous portosystemic shunts in cirrhotics: implications for orthotopic liver transplantation. (PubMedID: 8442063) Transplantation proceedings
02/01/1993
Liver transplantation for alcoholic cirrhosis--do they mix? (PubMedID: 8442064) Transplantation proceedings
02/01/1993
Orthotopic liver transplantation for end-stage alcoholic liver disease. (PubMedID: 8442065) Transplantation proceedings
02/01/1993
Results and cost of orthotopic liver transplantation for alcoholic cirrhosis. (PubMedID: 8442066) Transplantation proceedings
02/01/1993
Report from the Pitt-UNOS Liver Transplant Registry. (PubMedID: 8442067) Transplantation proceedings
02/01/1993
Risk/benefit ratio of perioperative OKT3 in cardiac transplantation. (PubMedID: 8442068) Transplantation proceedings
02/01/1993
Donor-transmitted bacterial infection in heart-lung transplantation. (PubMedID: 8442069) Transplantation proceedings
02/01/1993
Comparison of hemodynamic outcome of patients with pulmonary hypertension after double-lung or heart-lung transplantation. (PubMedID: 8442070) Transplantation proceedings
02/01/1993
Transplantation for pulmonary hypertension. (PubMedID: 8442071) Transplantation proceedings
02/01/1993
High-affinity cytotoxic T lymphocytes in the graft of heart transplant patients with rejection. (PubMedID: 8442072) Transplantation proceedings
02/01/1993
Airway complications after lung and heart-lung transplantation. (PubMedID: 8442073) Transplantation proceedings
02/01/1993
Pathology of unused donor lungs. (PubMedID: 8442074) Transplantation proceedings
02/01/1993
Late airway changes in rat lung allografts: chronic rejection is a causative factor. (PubMedID: 8442075) Transplantation proceedings
02/01/1993
Atrioventricular orthotopic heart transplantation: a prospective randomised clinical trial in 60 consecutive patients. (PubMedID: 8442076) Transplantation proceedings
02/01/1993
Coagulation disorders after reperfusion of pancreatic allografts. (PubMedID: 8442077) Transplantation proceedings
02/01/1993
Pancreas transplantation with portal venous and enteric drainage eliminates hyperinsulinemia and reduces postoperative complications. (PubMedID: 8442078) Transplantation proceedings
02/01/1993
Cystoenteric conversion after whole pancreaticoduodenal transplantation: indications, risk factors, and outcome. (PubMedID: 8442079) Transplantation proceedings
02/01/1993
Pancreas transplantation in the uremic patient: a random trial of total pancreas with bladder drainage versus duct obstruction of segmental grafts. (PubMedID: 8442080) Transplantation proceedings
02/01/1993
Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant? (PubMedID: 8442081) Transplantation proceedings
02/01/1993
Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT). (PubMedID: 8442082) Transplantation proceedings
02/01/1993
Retrospective analysis of the role of pancreatic biopsy (open and transcystoscopic technique) in the management of solitary pancreas transplants. (PubMedID: 8442083) Transplantation proceedings
02/01/1993
Biopsies from pancreas allografts at time of dysfunction: pathologic comparison of allografts which ultimately failed versus those which continued to function. (PubMedID: 8442084) Transplantation proceedings
02/01/1993
Selective mesenteric lymphoid irradiation eliminates the effector cells of lethal graft-versus-host disease while protecting radiosensitive intestinal tissue. (PubMedID: 8442085) Transplantation proceedings
02/01/1993
Immunosuppressive requirements for small bowel/liver transplantation. (PubMedID: 8442086) Transplantation proceedings
02/01/1993
Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation. (PubMedID: 8442087) Transplantation proceedings
02/01/1993
Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone. (PubMedID: 8442088) Transplantation proceedings
02/01/1993
Altered cell trafficking of mesenteric lymphocytes after heterotopic small bowel transplantation using systemic venous drainage. (PubMedID: 8442089) Transplantation proceedings
02/01/1993
Morphological monitoring of human small bowel allografts. (PubMedID: 8442090) Transplantation proceedings
02/01/1993
Surgical techniques for intestinal transplantation in the mouse. (PubMedID: 8442091) Transplantation proceedings
02/01/1993
Graft-versus-host disease in fully allogeneic small bowel transplantation: incidence of the disease and strain combinations. (PubMedID: 8442092) Transplantation proceedings
02/01/1993
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. (PubMedID: 8442093) Transplantation proceedings
02/01/1993
Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo. (PubMedID: 8442094) Transplantation proceedings
02/01/1993
Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation. (PubMedID: 8442095) Transplantation proceedings
02/01/1993
Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice. (PubMedID: 8442096) Transplantation proceedings
02/01/1993
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation. (PubMedID: 8442097) Transplantation proceedings
02/01/1993
Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in primary mixed-lymphocyte reaction: application in allogeneic bone marrow transplantation. (PubMedID: 8442098) Transplantation proceedings
02/01/1993
Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. (PubMedID: 8442099) Transplantation proceedings
02/01/1993
Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation. (PubMedID: 8442100) Transplantation proceedings
02/01/1993
Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors. (PubMedID: 8442101) Transplantation proceedings
02/01/1993
Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International Bone Marrow Transplant Registry. (PubMedID: 8442102) Transplantation proceedings
02/01/1993
Bone marrow transplantation with unrelated donors: HLA class II oligonucleotide typing as predictive of mixed lymphocyte culture reactivity. (PubMedID: 8442103) Transplantation proceedings
02/01/1993
Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment. (PubMedID: 8442104) Transplantation proceedings
02/01/1993
Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients. (PubMedID: 8442105) Transplantation proceedings
02/01/1993
Unrelated donor matching for bone marrow transplantation. (PubMedID: 8442106) Transplantation proceedings
02/01/1993
Natural killer defined haplotypes are associated with particular ancestral haplotypes: implications for bone marrow transplantation. (PubMedID: 8442107) Transplantation proceedings
02/01/1993
Protection against autoimmune diabetes by induction of mixed bone marrow chimerism. (PubMedID: 8442108) Transplantation proceedings
02/01/1993
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia. (PubMedID: 8442109) Transplantation proceedings
02/01/1993
Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders. (PubMedID: 8442110) Transplantation proceedings
02/01/1993
Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation. (PubMedID: 8442111) Transplantation proceedings
02/01/1993
Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation. (PubMedID: 8442112) Transplantation proceedings
02/01/1993
Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response. (PubMedID: 8442113) Transplantation proceedings
02/01/1993
Summation of the biologic aspects of the congress. (PubMedID: 8442114) Transplantation proceedings
02/01/1993
Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine. (PubMedID: 8442115) Transplantation proceedings
02/01/1993
Correlation of preoperative renal function and identification of risk factors for eventual native renal failure in cyclosporine-treated nonuremic diabetic recipient of pancreas transplants alone. (PubMedID: 8442116) Transplantation proceedings
02/01/1993
Impact of the addition of a pancreas to quality of life in uremic diabetic recipients of kidney transplants. (PubMedID: 8442117) Transplantation proceedings
02/01/1993
Patient rehabilitation following lung and heart-lung transplantation. (PubMedID: 8442118) Transplantation proceedings
02/01/1993
Combined pancreas-kidney transplantation versus kidney transplantation alone: analysis of benefit and risk. (PubMedID: 8442119) Transplantation proceedings
02/01/1993
Influence of pregnancy on kidney graft function. (PubMedID: 8442120) Transplantation proceedings
02/01/1993
Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. (PubMedID: 8442121) Transplantation proceedings
02/01/1993
Improvement in autonomic function following pancreas-kidney versus kidney-alone transplantation. (PubMedID: 8442122) Transplantation proceedings
02/01/1993
How "death with function" should be considered when calculating renal transplant outcome. (PubMedID: 8442123) Transplantation proceedings
02/01/1993
Frequency of platelet-specific antigens among Chinese in Taiwan. (PubMedID: 7679227) Transfusion
02/01/1993
More about use of the term Drb. (PubMedID: 7679228) Transfusion
02/01/1993
Transfusion and the human immunodeficiency virus. (PubMedID: 8430445) Transfusion
02/01/1993
Standards for bone marrow donation. (PubMedID: 8430446) Transfusion
02/01/1993
Human T-cell lymphotropic virus type I and II DNA amplification in seropositive and seronegative at-risk individuals. (PubMedID: 8430447) Transfusion
02/01/1993
Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. (PubMedID: 8430448) Transfusion
02/01/1993
Polymerase chain reaction-based detection of MN blood group-specific sequences in the human genome. (PubMedID: 8430449) Transfusion
02/01/1993
Prevention of transfusion-associated graft-versus-host disease: selection of an adequate dose of gamma radiation. (PubMedID: 8430450) Transfusion
02/01/1993
White cell-reduced red cells prepared by filtration: a critical evaluation of current filters and methods for counting residual white cells. (PubMedID: 8430451) Transfusion
02/01/1993
The mechanism of white cell reduction by synthetic fiber cell filters. (PubMedID: 8430452) Transfusion
02/01/1993
Collection and transfusion of blood and blood components in the United States, 1989. (PubMedID: 8430453) Transfusion
02/01/1993
The effect of solvent/detergent-treated plasma on stored platelet concentrates. (PubMedID: 8430454) Transfusion
02/01/1993
Complement activation in stored platelet concentrates. (PubMedID: 8430455) Transfusion
02/01/1993
Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation. (PubMedID: 8430456) Transfusion
02/01/1993
Human immunodeficiency virus type 1 nucleic acids detected before p24 antigenemia in a blood donor. (PubMedID: 8430457) Transfusion
02/01/1993
Reversal of microangiopathy in long-term diabetic patients after successful simultaneous pancreas-kidney transplants. (PubMedID: 8442124) Transplantation proceedings
02/01/1993
Pancreatic graft protects a simultaneously transplanted kidney from developing diabetic nephropathy: a 1- to 6-year follow-up study. (PubMedID: 8442125) Transplantation proceedings
02/01/1993
Modelling long-term survival in 52,315 first cadaveric grafts: the European experience. (PubMedID: 8442126) Transplantation proceedings
02/01/1993
Effect of center size and patient-mix covariates on transplant center-specific patient and graft survival in the United States. (PubMedID: 8442127) Transplantation proceedings
02/01/1993
Morbidity, mortality, and long-term allograft function in kidney transplantation alone and simultaneous pancreas-kidney in diabetic patients. (PubMedID: 8442128) Transplantation proceedings
02/01/1993
One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of age. (PubMedID: 8442129) Transplantation proceedings
02/01/1993
Adaptation and long-term function of transplanted kidneys in children. (PubMedID: 8442130) Transplantation proceedings
02/01/1993
Long-term follow-up after heart transplantation in Chagas' disease. (PubMedID: 8442131) Transplantation proceedings
02/01/1993
One thousand years of continuous function in 49 renal transplant recipients: clinical, renal, and immunologic features of 20-year successes. (PubMedID: 8442132) Transplantation proceedings
02/01/1993
Characteristics of long-term survivors (> 20 years) after kidney transplantation. (PubMedID: 8442133) Transplantation proceedings
02/01/1993
Status of long-term (25 years) survival of kidney transplant patients. (PubMedID: 8442134) Transplantation proceedings
02/01/1993
Renal transplantation and intestinal urinary diversion: a 10-year experience. (PubMedID: 8442135) Transplantation proceedings
02/01/1993
Causes of late graft failure in cadaveric renal transplantation. (PubMedID: 8442136) Transplantation proceedings
02/01/1993
Life survival and transplanted kidney survival after pancreas transplantation in uremic diabetic patients. (PubMedID: 8442137) Transplantation proceedings
02/01/1993
Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis. (PubMedID: 8442138) Transplantation proceedings
02/01/1993
Allograft biopsies in situ hybridization HBVDNA detection of serum HBs Ag-repositive patients treated with anti-HBV immunoprophylaxis after liver transplantation for HBV cirrhosis. (PubMedID: 8442139) Transplantation proceedings
02/01/1993
Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients. (PubMedID: 8442140) Transplantation proceedings
02/01/1993
Should abdominal cluster transplantation be abandoned? (PubMedID: 8442141) Transplantation proceedings
02/01/1993
Thrombospondin and the expression of adhesion molecules in acute and chronic renal transplant rejection. (PubMedID: 8442142) Transplantation proceedings
02/01/1993
Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin. (PubMedID: 8442143) Transplantation proceedings
02/01/1993
Simultaneous pancreatic and kidney transplantation before end-stage chronic renal failure. (PubMedID: 8442144) Transplantation proceedings
02/01/1993
Employment and disability after renal transplantation. (PubMedID: 8442145) Transplantation proceedings
02/01/1993
Focal rejection: a cause of false-negative biopsy results? (PubMedID: 8442146) Transplantation proceedings
02/01/1993
Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice. (PubMedID: 8442147) Transplantation proceedings
02/01/1993
Effects of renal transplantation on apoproteins: decrease in the B/A1 ratio atherogenicity index. (PubMedID: 8442148) Transplantation proceedings
02/01/1993
Effect of immunosuppression on preexisting cancers. (PubMedID: 8442149) Transplantation proceedings
02/01/1993
De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. (PubMedID: 8442150) Transplantation proceedings
02/01/1993
Oncogene-derived peptides: a new class of tumor rejection antigens? (PubMedID: 8442151) Transplantation proceedings
02/01/1993
Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period. (PubMedID: 8442152) Transplantation proceedings
02/01/1993
De novo malignancy following liver transplantation: a single-center study. (PubMedID: 8442153) Transplantation proceedings
02/01/1993
Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. (PubMedID: 8442154) Transplantation proceedings
02/01/1993
Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. (PubMedID: 8442155) Transplantation proceedings
02/01/1993
Long-term outcome of hepatitis B after renal transplantation during childhood. (PubMedID: 8442156) Transplantation proceedings
02/01/1993
Impact of hepatitis B or C infection on the practice of kidney transplantation in the United States. (PubMedID: 8442157) Transplantation proceedings
02/01/1993
Use of low-risk HCV-positive donors for kidney transplantation. (PubMedID: 8442158) Transplantation proceedings
02/01/1993
Impact asymptomatic HIV-1 infection on renal allograft recipients. (PubMedID: 8442159) Transplantation proceedings
02/01/1993
Kidney transplantations with HBsAg+ donors. (PubMedID: 8442160) Transplantation proceedings
02/01/1993
Risk of AIDS (HIV) transmission in 581 renal transplants. (PubMedID: 8442161) Transplantation proceedings
02/01/1993
Corynebacterium urealyticum: a new and threatening pathogen for the renal transplant patient. (PubMedID: 8442162) Transplantation proceedings
02/01/1993
Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. (PubMedID: 8442163) Transplantation proceedings
02/01/1993
Cardiopulmonary bypass and profound hypothermia as a means for obtaining kidney grafts from irreversible cardiac arrest donors: cooling technique. (PubMedID: 8442164) Transplantation proceedings
02/01/1993
In situ perfusion of kidneys from non-heart-beating donors: the Maastricht protocol. (PubMedID: 8442165) Transplantation proceedings
02/01/1993
Renal harvesting after in situ cooling by intra-aortic double-balloon catheter. (PubMedID: 8442166) Transplantation proceedings
02/01/1993
Technical aspects of organ procurement from the non-heart-beating cadaver donor for clinical transplantation. (PubMedID: 8442167) Transplantation proceedings
02/01/1993
Is warm ischemia the main limiting factor in the use of non-heart-beating donors in renal transplantation? (PubMedID: 8442168) Transplantation proceedings
02/01/1993
Use of kidneys from marginal and non-heart-beating donors: warm ischemia per se is not the most detrimental factor. (PubMedID: 8442169) Transplantation proceedings
02/01/1993
Update of our experience in long-term renal function of kidneys transplanted from non-heart-beating cadaver donors. (PubMedID: 8442170) Transplantation proceedings
02/01/1993
Effect of combination in situ cooling and machine perfusion preservation on non-heart-beating donor kidney procurement. (PubMedID: 8442171) Transplantation proceedings
02/01/1993
Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: associated with secondary grafts and early cyclosporine treatment? (PubMedID: 8442172) Transplantation proceedings
02/01/1993
Long-term follow-up of transplanted non-heart-beating donor kidneys: preliminary results of a retrospective study. (PubMedID: 8442173) Transplantation proceedings
02/01/1993
Exploration of the system for cadaver kidney transplantation with the non-heart-beating donor: efficacy of in situ cooling and low-dose cyclosporine. (PubMedID: 8442174) Transplantation proceedings
02/01/1993
Comparative study of the use of systolic and asystolic kidney donors between 1988 and 1991. The South Thames Transplant Group. (PubMedID: 8442175) Transplantation proceedings
02/01/1993
Transplantation of kidneys from zero haplotype-matched living donors and from distantly related and unrelated donors in the cyclosporine era. (PubMedID: 8442176) Transplantation proceedings
02/01/1993
Living unrelated kidney donation: an underutilized resource? (PubMedID: 8442177) Transplantation proceedings
02/01/1993
Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. (PubMedID: 8442178) Transplantation proceedings
02/01/1993
Impact of glycogen content of the donor liver in clinical liver transplantation. (PubMedID: 8442179) Transplantation proceedings
02/01/1993
Effluent levels of hyaluronic acid can predict ultimate graft outcome after clinical liver transplantation: a prospective series. (PubMedID: 8442180) Transplantation proceedings
02/01/1993
Estimates of organ-specific donor availability for the United States. (PubMedID: 8442181) Transplantation proceedings
02/01/1993
Effects of cold ischemia time on cadaver renal allografts. (PubMedID: 8442182) Transplantation proceedings
02/01/1993
Preliminary experience with a new liver allocation system within Eurotransplant. (PubMedID: 8442183) Transplantation proceedings
02/01/1993
Utilization of available paediatric donor livers in the United Kingdom. (PubMedID: 8442184) Transplantation proceedings
02/01/1993
Triiodothyronine treatment is not indicated in brain-dead multiorgan donors: a controlled study. (PubMedID: 8442185) Transplantation proceedings
02/01/1993
Kidneys from cadaveric donors over 60 years of age. (PubMedID: 8442186) Transplantation proceedings
02/01/1993
Liver transplantation from elderly donors. (PubMedID: 8442187) Transplantation proceedings
02/01/1993
Impaired initial function in liver grafts from donors > 50 years of age. (PubMedID: 8442188) Transplantation proceedings
02/01/1993
94 consecutive living unrelated kidney transplants: 8-year graft and patient actuarial survival. (PubMedID: 8442189) Transplantation proceedings
02/01/1993
Outcome of 1128 proposals for liver donation from brain-dead patients: a 1-year prospective study in Paris centers. (PubMedID: 8442190) Transplantation proceedings
02/01/1993
Measurement of the potential for cadaveric organ retrieval in New South Wales, Australia. (PubMedID: 8442191) Transplantation proceedings
02/01/1993
Transplantation of the extreme age donor kidneys. (PubMedID: 8442192) Transplantation proceedings
02/01/1993
Outcome of cadaver kidneys using nonideal donors. (PubMedID: 8442193) Transplantation proceedings
02/01/1993
Is it safe to liberalize donor criteria to include those over age 60 and those weighing over 90 kg? (PubMedID: 8442194) Transplantation proceedings
02/01/1993
Renal transplantation in highly sensitized patients using the regional organ procurement crossmatch tray: the SEOPF kidney sharing system experience. (PubMedID: 8442195) Transplantation proceedings
02/01/1993
Carolina rinse solution decreases liver injury during clinical liver transplantation. (PubMedID: 8442196) Transplantation proceedings
02/01/1993
Simple cold storage of the heart with the University of Wisconsin solution: evaluation in canine heterotopically and orthotopically transplanted heart. (PubMedID: 8442197) Transplantation proceedings
02/01/1993
Current status of the Eurotransplant randomized multicenter study comparing kidney graft preservation with histidine-tryptophan-ketogluterate, University of Wisconsin, and Euro-Collins solutions. The HTK Study Group. (PubMedID: 8442198) Transplantation proceedings
02/01/1993
Kidney preservation with University of Wisconsin or Euro-Collins solution? An economic analysis. (PubMedID: 8442199) Transplantation proceedings
02/01/1993
Canine and cadaver kidney preservation with sodium lactobionate sucrose solution. (PubMedID: 8442200) Transplantation proceedings
02/01/1993
Disturbance of microcirculation associated with prolonged preservation of dog livers under University of Wisconsin solution. (PubMedID: 8442201) Transplantation proceedings
02/01/1993
Endothelial cell kinetics after anoxia and hypothermia in preservation solutions as indicators of endothelial repair. (PubMedID: 8442202) Transplantation proceedings
02/01/1993
Twenty-four-hour preservation of canine pancreas allografts using low-cost, low-viscosity, modified University of Wisconsin cold storage solution. (PubMedID: 8442203) Transplantation proceedings
02/01/1993
Successful 12-hour lung preservation with trehalose. (PubMedID: 8442204) Transplantation proceedings
02/01/1993
Efficacy of University of Wisconsin solution for canine lung preservation. (PubMedID: 8442205) Transplantation proceedings
02/01/1993
Comparison of University of Wisconsin and Stanford solution for heart preservation: coronary flow reserve in the posttransplant myocardium. (PubMedID: 8442206) Transplantation proceedings
02/01/1993
Effects of abdominal en bloc procurement and of a high sodium preservation solution in liver transplantation. (PubMedID: 8442207) Transplantation proceedings
02/01/1993
Importance of rinse solution vs preservation solution in prevention of microcirculatory damage after liver transplantation in the rat. (PubMedID: 8442208) Transplantation proceedings
02/01/1993
Clinical study of crystalloid cardioplegia vs aspartate-enriched cardioplegia plus warm reperfusion for donor heart preservation. (PubMedID: 8442209) Transplantation proceedings
02/01/1993
Preservation of small bowel with University of Wisconsin and Euro-Collins solution. (PubMedID: 8442210) Transplantation proceedings
02/01/1993
Relative advantages of nondepolarizing solution to depolarizing University of Wisconsin solution in donor heart preservation. (PubMedID: 8442211) Transplantation proceedings
02/01/1993
Sodium lactobionate sucrose solution for canine liver and kidney preservation. (PubMedID: 8442212) Transplantation proceedings
02/01/1993
Ultrastructural correlates of liver graft failure from storage injury: studies of graft protection by Carolina rinse solution and pentoxifylline. (PubMedID: 8442213) Transplantation proceedings
02/01/1993
Improved myocardial preservation by modification of the University of Wisconsin solution with 2,3-butanedione monoxime and calcium. (PubMedID: 8442214) Transplantation proceedings
02/01/1993
Effect of thromboxane A2 synthesis inhibitor OKY046 on canine pancreas and kidney preservation. (PubMedID: 8442215) Transplantation proceedings
02/01/1993
Prolonged kidney preservation by inhibition of arachidonic acid metabolism. (PubMedID: 8442216) Transplantation proceedings
02/01/1993
Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. (PubMedID: 8442217) Transplantation proceedings
02/01/1993
Effect of glutathione and glycine in kidney preservation. (PubMedID: 8442218) Transplantation proceedings
02/01/1993
Microcirculatory effects of adenosine in rinse solution for liver transplantation in the rat. (PubMedID: 8442219) Transplantation proceedings
02/01/1993
Functional integrity of vascular endothelium correlates with myocardial function in stored rabbit hearts. (PubMedID: 8442220) Transplantation proceedings
02/01/1993
Successful 7-day perfusion preservation of the canine kidney. (PubMedID: 8442221) Transplantation proceedings
02/01/1993
Prolonged ischemic times in pediatric heart transplantation: early and late results. (PubMedID: 8442222) Transplantation proceedings
02/01/1993
Graft function, airway healing, rejection, and survival in pulmonary transplantation are not affected by graft ischemia in excess of 5 hours. (PubMedID: 8442223) Transplantation proceedings
02/01/1993
Biliary complications after prolonged University of Wisconsin preservation of liver allografts. (PubMedID: 8442224) Transplantation proceedings
02/01/1993
Limits of the MEGX test in the selection of liver grafts for transplantation. (PubMedID: 8442225) Transplantation proceedings
02/01/1993
Safe use of liver donors with MEGX values less than 90 ng/mL. (PubMedID: 8442226) Transplantation proceedings
02/01/1993
Assessment of viability of hepatic cell membrane after cold storage by 31P-NMR and 23Na-NMR spectroscopy. (PubMedID: 8442227) Transplantation proceedings
02/01/1993
Malfunction of the liver after transplantation: an analysis of potential risk factors. (PubMedID: 8442228) Transplantation proceedings
02/01/1993
Histological comparison of donor livers and lidocaine metabolism in the utilization of organs for liver transplantation. (PubMedID: 8442229) Transplantation proceedings
02/01/1993
Study of the toxicity of various concentrations of 2-3-butanediol in the isolated perfused rat liver. (PubMedID: 8442230) Transplantation proceedings
02/01/1993
Comparison of cold and warm ischemic injury in hepatocytes from the rat liver. (PubMedID: 8442231) Transplantation proceedings
02/01/1993
Heat shock and recovery protects renal allografts from warm ischemic injury and enhances HSP72 production. (PubMedID: 8442232) Transplantation proceedings
02/01/1993
Importance of protection of cold-stored small intestine against oxygen free-radical-induced injury during the initial period of reperfusion. (PubMedID: 8442233) Transplantation proceedings
02/01/1993
Lipid peroxidation of parenchymal and nonparenchymal hepatocytes during cold preservation and after reoxygenation in rats. (PubMedID: 8442234) Transplantation proceedings
02/01/1993
Role of xanthine-oxidase system in mucosal injury after intestinal preservation and transplantation. (PubMedID: 8442235) Transplantation proceedings
02/01/1993
Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting. (PubMedID: 8442236) Transplantation proceedings
02/01/1993
Transplantation--the issues: a cross curriculum programme for secondary schools. (PubMedID: 8442237) Transplantation proceedings
02/01/1993
Relationship between clinical outcome, inpatient length of stay, and cost of renal transplantation at four US transplant centers. (PubMedID: 8442238) Transplantation proceedings
02/01/1993
Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy. (PubMedID: 8442239) Transplantation proceedings
02/01/1993
Is retransplantation cost effective? (PubMedID: 8442240) Transplantation proceedings
02/01/1993
Toward a European charter for transplantation ethics. (PubMedID: 8442241) Transplantation proceedings
02/01/1993
Donor families' attitude toward organ donation. The North Italy Transplant Program. (PubMedID: 8442242) Transplantation proceedings
02/01/1993
Influence of social support and study course on attitudes of 18-year-old students toward cadaveric organ donation and transplantation. (PubMedID: 8442243) Transplantation proceedings
02/01/1993
Tabulation of cases from the International Pancreas Transplant Registry and analysis of United Network for Organ Sharing United States Pancreas Transplant Registry data according to multiple variables. (PubMedID: 8442244) Transplantation proceedings
02/01/1993
Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection. (PubMedID: 8442245) Transplantation proceedings
02/01/1993
Immunopathology of liver allografts and xenografts in nonhuman primates. (PubMedID: 8442246) Transplantation proceedings
02/01/1993
Not donor but recipient dendritic cells are involved in human renal rejection. (PubMedID: 8442247) Transplantation proceedings
02/01/1993
Coronary arteriopathy postcardiac transplant in a heterotopic piglet model: the role of matrix-cytokine interaction. (PubMedID: 8442248) Transplantation proceedings
02/01/1993
Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model. (PubMedID: 8442249) Transplantation proceedings
02/01/1993
T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. (PubMedID: 8442250) Transplantation proceedings
02/01/1993
Evidence that liver grafting suppresses allograft rejection and controls graft-vs-host reaction. (PubMedID: 8442251) Transplantation proceedings
02/01/1993
Endothelial adhesion molecules in human liver grafts: overview on the differential expression of leukocyte ligand molecules. (PubMedID: 8442252) Transplantation proceedings
02/01/1993
Tyrosine kinase-dependent lymphocyte signaling during allograft rejection. (PubMedID: 8442253) Transplantation proceedings
02/01/1993
Vascular rejection diagnosis correlates with the development of donor-specific antibodies and with macrophage infiltration of the graft. (PubMedID: 8442254) Transplantation proceedings
02/01/1993
Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: a preliminary clinical and immunopathologic report. (PubMedID: 8442255) Transplantation proceedings
02/01/1993
Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. (PubMedID: 8442256) Transplantation proceedings
02/01/1993
Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts. (PubMedID: 8442257) Transplantation proceedings
02/01/1993
Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. (PubMedID: 8442258) Transplantation proceedings
02/01/1993
Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss. (PubMedID: 8442259) Transplantation proceedings
02/01/1993
Host cell infiltration of the intraepithelial compartment in small bowel transplantation. (PubMedID: 8442260) Transplantation proceedings
02/01/1993
Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. (PubMedID: 8442261) Transplantation proceedings
02/01/1993
Acute early allograft failure and the C3/macrophage phenomenon. (PubMedID: 8442262) Transplantation proceedings
02/01/1993
Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes. (PubMedID: 8442263) Transplantation proceedings
02/01/1993
Changes of chronic kidney allograft rejection are reversible after retransplantation. (PubMedID: 8442264) Transplantation proceedings
02/01/1993
Relationship between early vs late acute rejection and onset of chronic rejection in kidney transplantation. (PubMedID: 8442265) Transplantation proceedings
02/01/1993
Kidneys from female donors are at increased risk for chronic allograft rejection. (PubMedID: 8442266) Transplantation proceedings
02/01/1993
Chronic rejection of rat renal allografts: a novel subpopulation of infiltrating leukocytes in long-term surviving allografts. (PubMedID: 8442267) Transplantation proceedings
02/01/1993
Implications of lymphocyte sensitivity to glucocorticoids in renal transplant recipients. (PubMedID: 8442268) Transplantation proceedings
02/01/1993
Computer-assisted densitometric analysis for quantification of cell surface antigen expression in monkey cardiac allografts: correspondence to histopathologic grade of rejection. (PubMedID: 8442269) Transplantation proceedings
02/01/1993
Daily determinations of serum lymphotoxin allows for accurate early diagnosis of hepatic allograft rejection. (PubMedID: 8442270) Transplantation proceedings
02/01/1993
Characterization of antiendothelial cell and antiheart antibodies following heart transplantation. (PubMedID: 8442271) Transplantation proceedings
02/01/1993
Effect of immunosuppression on chronic rejection in the rat aortic allograft model. (PubMedID: 8442272) Transplantation proceedings
02/01/1993
Predictors of chronic rejection in renal transplant recipients. (PubMedID: 8442273) Transplantation proceedings
02/01/1993
Neutrophils and macrophages are prominent in the pathophysiology of chronic rejection of rat kidney allografts. (PubMedID: 8442274) Transplantation proceedings
02/01/1993
Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients. (PubMedID: 8442275) Transplantation proceedings
02/01/1993
Eosinophiluria as an indicator of kidney-pancreas transplant rejection. (PubMedID: 8442276) Transplantation proceedings
02/01/1993
Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts. (PubMedID: 8442277) Transplantation proceedings
02/01/1993
Human islet purification with discontinuous density gradients following cold storage of the pancreas. (PubMedID: 8442278) Transplantation proceedings
02/01/1993
Isokinetic gradients: a new approach to reduce islet graft immunogenicity. (PubMedID: 8442279) Transplantation proceedings
02/01/1993
Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients. (PubMedID: 8442280) Transplantation proceedings
02/01/1993
Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse. (PubMedID: 8442281) Transplantation proceedings
02/01/1993
Occurrence and prevention of graft-vs-host disease after pancreaticoduodenal transplantation in the BB rat. (PubMedID: 8442282) Transplantation proceedings
02/01/1993
Isolation of functional MHC class I-deficient islet cells. (PubMedID: 8442283) Transplantation proceedings
02/01/1993
Transplantation of porcine fetal islet-like cell clusters into eight diabetic patients. (PubMedID: 8442284) Transplantation proceedings
02/01/1993
Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine. (PubMedID: 8442285) Transplantation proceedings
02/01/1993
Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment. (PubMedID: 8442286) Transplantation proceedings
02/01/1993
Combined transplantation of islets and kidney: immunogenetic analysis in the rat. (PubMedID: 8442287) Transplantation proceedings
02/01/1993
Transplantation of islet allografts using a diffusion-based biohybrid artificial pancreas: long-term studies in diabetic, pancreatectomized dogs. (PubMedID: 8442288) Transplantation proceedings
02/01/1993
Islet and hepatocyte cotransplantation in rats. (PubMedID: 8442289) Transplantation proceedings
02/01/1993
Allo- and autotransplantation of porcine islets beneath the renal capsule and into the portal vein. (PubMedID: 8442290) Transplantation proceedings
02/01/1993
Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. (PubMedID: 8442291) Transplantation proceedings
02/01/1993
Reduction in primary nonfunction of pancreas islet transplants with antithymocyte globulin agents, deoxyspergualin, and splenectomy. (PubMedID: 8442292) Transplantation proceedings
02/01/1993
Intrapancreatic islet transplantation as a potential solution to chronic failure of intraportal islet grafts. (PubMedID: 8442293) Transplantation proceedings
02/01/1993
Allotransplantation of fresh and cryopreserved islets in patients with type I diabetes: two-year experience. (PubMedID: 8442294) Transplantation proceedings
02/01/1993
Reversal of type II diabetes by pancreas islet transplant in four separate animal models of type II diabetes. (PubMedID: 8442295) Transplantation proceedings
02/01/1993
Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible. (PubMedID: 8442296) Transplantation proceedings
02/01/1993
Enterocyte transplantation using cell-polymer devices to create intestinal epithelial-lined tubes. (PubMedID: 8442297) Transplantation proceedings
02/01/1993
Consent for organ donation: what are the ethical principles? (PubMedID: 11655153) Transplantation proceedings
02/01/1993
Regulated commercialism of vital organ donation: a necessity? Con. (PubMedID: 11655154) Transplantation proceedings
02/01/1993
A futures market in cadaveric organs: would it work? (PubMedID: 11655155) Transplantation proceedings